GlassScriptPhysician profile
Linda Bernstein
NPI 1063744142
$6,007.93
in general payments reported to CMS, 2019-2025
43 companies · $1,239 in 2025
The $1,239 reported for 2025 was more than what 92% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $357 · 2020: $196 · 2021: $540 · 2022: $409 · 2023: $475 · 2024: $2,793 · 2025: $1,239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,778 · Education: $1,699 · Travel and Lodging: $1,028.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,778.39 |
| Education | $1,698.99 |
| Travel and Lodging | $1,028.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,065.67 | 2024-2025 | |
| Abbvie INC. | $602.80 | 2019-2024 | Lo Loestrin Fe |
| Astellas Pharma US INC | $472.35 | 2022-2025 | Veozah |
| Mayne Pharma Commercial LLC | $201.94 | 2023-2025 | |
| Exeltis, USA INC. | $175.38 | 2019-2025 | Slynd, Solosec |
| Biogen, INC. | $156.09 | 2024-2025 | Vumerity, Zurzuvae |
| Novo Nordisk INC | $145.97 | 2020-2024 | Wegovy |
| Hologic Sales and Service, LLC | $97.81 | 2019-2025 | Novasure, Myosure Tissue Removal Device |
| Almatica Pharma LLC | $77.06 | 2025 | Loreev Xr |
| Orexo US, INC. | $69.88 | 2019-2024 | Zubsolv |
| Antares Pharma, INC. | $68.09 | 2019-2021 | |
| Avion Pharmaceuticals | $66.35 | 2019-2020 | |
| Indivior INC. | $54.49 | 2019-2020 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $50.59 | 2025 | Caplyta |
| Azurity Pharmaceuticals, INC. | $43.80 | 2025 | Azmiro |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Linda Bernstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.